BeOne Medicines
ONC
#590
Rank
C$58.92 B
Marketcap
C$517.96
Share price
-0.33%
Change (1 day)
20.20%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$8.37

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$8.36. In 2025 the company made an earnings per share (EPS) of C$3.82 an increase over its 2024 EPS that were of C-$8.73.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$8.37119.09%
2025C$3.82-143.75%
2024C-$8.73
2022C-$27.2728.21%
2021C-$21.27-19.96%
2020C-$26.5820.81%
2019C-$22.0031.52%
2018C-$16.73417.57%
2017C-$3.23-37.16%
2016C-$5.14158.95%
2015C-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.33-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA